Theriva Biologics, Inc. (TOVX)
NYSEAMERICAN: TOVX · Real-Time Price · USD
0.4378
+0.0081 (1.89%)
At close: Aug 13, 2025, 4:00 PM
0.4378
0.00 (0.00%)
Pre-market: Aug 14, 2025, 8:04 AM EDT
Theriva Biologics Employees
Theriva Biologics had 22 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
22
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,343,364
Market Cap
3.97M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TOVX News
- 3 days ago - Theriva™ Biologics Reports Second Quarter 2025 Operational Highlights and Financial Results - GlobeNewsWire
- 3 months ago - Theriva™ Biologics Reports First Quarter 2025 Operational Highlights and Financial Results - GlobeNewsWire
- 3 months ago - Theriva Biologics Announces Closing of $7.5 Million Public Offering - GlobeNewsWire
- 3 months ago - Theriva Biologics Announces Pricing of $7.5 Million Public Offering - GlobeNewsWire
- 4 months ago - Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients - GlobeNewsWire
- 5 months ago - Theriva™ Biologics to Present at the 2025 NeauxCancer Conference - GlobeNewsWire
- 5 months ago - Theriva™ Biologics Reports Full-Year 2024 Operational Highlights and Financial Results - GlobeNewsWire
- 5 months ago - Theriva™ Biologics to Participate in the Q1 Investor Summit Virtual - GlobeNewsWire